These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37840598)

  • 1. CRISPR-based Biosensors for Human Health: A Novel Strategy to Detect Emerging Infectious Diseases.
    He Y; Hu Q; San S; Kasputis T; Splinter MGD; Yin K; Chen J
    Trends Analyt Chem; 2023 Nov; 168():. PubMed ID: 37840598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Opportunities for Clustered Regularly Interspaced Short Palindromic Repeats Based Molecular Biosensing.
    Bao M; Chen Q; Xu Z; Jensen EC; Liu C; Waitkus JT; Yuan X; He Q; Qin P; Du K
    ACS Sens; 2021 Jul; 6(7):2497-2522. PubMed ID: 34143608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of CRISPR/Cas-based biosensors for detecting nucleic acid of pathogens].
    Liu T; Tian Y; Liu C; Fang S; Wu Y; Wu M; Li B; Yang H; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3890-3904. PubMed ID: 34841793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustered Regularly Interspaced short palindromic repeats-Based Microfluidic System in Infectious Diseases Diagnosis: Current Status, Challenges, and Perspectives.
    Xie Y; Li H; Chen F; Udayakumar S; Arora K; Chen H; Lan Y; Hu Q; Zhou X; Guo X; Xiu L; Yin K
    Adv Sci (Weinh); 2022 Dec; 9(34):e2204172. PubMed ID: 36257813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements of CRISPR technology in public health-related analysis.
    Gu X; Tang Q; Zhu Y; Sun C; Wu L; Ji H; Wang Q; Wu L; Qin Y
    Biosens Bioelectron; 2024 Oct; 261():116449. PubMed ID: 38850734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification-free CRISPR/Cas detection technology: challenges, strategies, and perspectives.
    Li H; Xie Y; Chen F; Bai H; Xiu L; Zhou X; Guo X; Hu Q; Yin K
    Chem Soc Rev; 2023 Jan; 52(1):361-382. PubMed ID: 36533412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Biosensing Technologies for the Diagnostics of Viral Infectious Diseases.
    Kabay G; DeCastro J; Altay A; Smith K; Lu HW; Capossela AM; Moarefian M; Aran K; Dincer C
    Adv Mater; 2022 Jul; 34(30):e2201085. PubMed ID: 35288985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease.
    Liu X; Hussain M; Dai J; Li Y; Zhang L; Yang J; Ali Z; He N; Tang Y
    Biol Proced Online; 2022 Jan; 24(1):2. PubMed ID: 35067222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and bioapplication of CRISPR-based one-step, quantitative and multiplexed infectious disease diagnostics.
    Shen Y; Hu K; Yuan M; Duan G; Guo Y; Chen S
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36813257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas Systems-Inspired Nano/Biosensors for Detecting Infectious Viruses and Pathogenic Bacteria.
    Zhang X; Shi Y; Chen G; Wu D; Wu Y; Li G
    Small Methods; 2022 Oct; 6(10):e2200794. PubMed ID: 36114150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Detection of Influenza A and B Viruses by CRISPR-Cas12a-Based Assay.
    Park BJ; Park MS; Lee JM; Song YJ
    Biosensors (Basel); 2021 Mar; 11(3):. PubMed ID: 33808752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas-Based MicroRNA Biosensors.
    Zhang Q; Zhang X; Zou X; Ma F; Zhang CY
    Chemistry; 2023 Mar; 29(16):e202203412. PubMed ID: 36477884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in CRISPR-Based Biosensors for Point-of-Care Pathogen Detection.
    Mohammad N; Katkam SS; Wei Q
    CRISPR J; 2022 Aug; 5(4):500-516. PubMed ID: 35856644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.
    Weng Z; You Z; Yang J; Mohammad N; Lin M; Wei Q; Gao X; Zhang Y
    Angew Chem Int Ed Engl; 2023 Apr; 62(17):e202214987. PubMed ID: 36710268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards CRISPR powered electrochemical sensing for smart diagnostics.
    Priya Swetha PD; Sonia J; Sapna K; Prasad KS
    Curr Opin Electrochem; 2021 Dec; 30():100829. PubMed ID: 34909513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas and Argonaute-Based Biosensors for Pathogen Detection.
    Yang Z; Mao S; Wang L; Fu S; Dong Y; Jaffrezic-Renault N; Guo Z
    ACS Sens; 2023 Oct; 8(10):3623-3642. PubMed ID: 37819690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas12a-based technology: A powerful tool for biosensing in food safety.
    Mao Z; Chen R; Wang X; Zhou Z; Peng Y; Li S; Han D; Li S; Wang Y; Han T; Liang J; Ren S; Gao Z
    Trends Food Sci Technol; 2022 Apr; 122():211-222. PubMed ID: 35250172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.